Improved therapy of experimental leishmaniasis by use of a liposome-encapsulated antimonial drug.
D000818:Animals; D006224:Cricetinae; D007896:Leishmaniasis / Q000188:drug therapy*; D008081:Liposomes; D008536:Meglumine / Q000008:administration & dosage / Q000627:therapeutic use*; D008647:Mesocricetus; D013012:Sorbitol / Q000031:analogs & derivatives*; D013997:Time Factors
D008081:Liposomes; D013012:Sorbitol; D008536:Meglumine